{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T22:39:08Z","timestamp":1778884748356,"version":"3.51.4"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T00:00:00Z","timestamp":1543881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000200","name":"USAID","doi-asserted-by":"crossref","award":["TREAT-TB"],"award-info":[{"award-number":["TREAT-TB"]}],"id":[{"id":"10.13039\/100000200","id-type":"DOI","asserted-by":"crossref"}]},{"name":"WHO\/TDR","award":["SORT-IT"],"award-info":[{"award-number":["SORT-IT"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206658","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T13:30:30Z","timestamp":1543930230000},"page":"e0206658","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014"],"prefix":"10.1371","volume":"13","author":[{"given":"Jose Gabriel","family":"Cornejo Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina Antonieta","family":"Alarc\u00f3n Guizado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Mendoza Ticona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Alarcon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Einar","family":"Heldal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3748-0154","authenticated-orcid":true,"given":"David A. J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,12,4]]},"reference":[{"key":"ref1","unstructured":"World Health Organization. Global Tuberculosis Report 2014 2014 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/apps.who.int\/iris\/bitstream\/10665\/137094\/1\/9789241564809_eng.pdf\" xlink:type=\"simple\">http:\/\/apps.who.int\/iris\/bitstream\/10665\/137094\/1\/9789241564809_eng.pdf<\/ext-link>."},{"issue":"3","key":"ref2","first-page":"278","article-title":"Vigilancia nacional de la resistencia a medicamentos antituberculosos, Per\u00fa 2005\u20132006","volume":"26","author":"L Asencios","year":"2009","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"ref3","unstructured":"World Health Organization. Implementing the End TB strategy: the essentials 2015 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/publications\/2015\/end_tb_essential.pdf\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/publications\/2015\/end_tb_essential.pdf<\/ext-link>."},{"issue":"7","key":"ref4","first-page":"760","article-title":"Validation of a rapid method for detection of M. tuberculosis resistance to isoniazid and rifampin in Lima, Peru","volume":"9","author":"L Solis","year":"2005","journal-title":"Int J Tuberc Lung Dis"},{"issue":"11","key":"ref5","first-page":"1475","article-title":"MODS accreditation process for regional reference laboratories in Peru: validation by GenoType MTBDRplus","volume":"14","author":"J Coronel","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1590\/S1726-46342012000100014","article-title":"Molecular test Genotype MTBDRplus, an alternative to rapid detection of multidrug resistance tuberculosis","volume":"29","author":"L Asencios","year":"2012","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"ref7","unstructured":"Ministerio de Salud del Per\u00fa. Plan de Emergencia para la Prevenci\u00f3n y Control de la Tuberculosis en Lima Metropolitana y el Callao, 2015\u20132017 2015 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.tuberculosis.minsa.gob.pe\/\" xlink:type=\"simple\">http:\/\/www.tuberculosis.minsa.gob.pe\/<\/ext-link>."},{"issue":"7","key":"ref8","first-page":"536","article-title":"Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998","volume":"53","year":"1998","journal-title":"Joint Tuberculosis Committee of the British Thoracic Society. Thorax"},{"key":"ref9","unstructured":"National Institute for Health and Care Excellence NICE. Tuberculosis 2016 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.nice.org.uk\/guidance\/ng33\/resources\/tuberculosis-1837390683589\" xlink:type=\"simple\">https:\/\/www.nice.org.uk\/guidance\/ng33\/resources\/tuberculosis-1837390683589<\/ext-link>."},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"H Blumberg","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"ref11","unstructured":"World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Emergency update 2008 2008 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/publications\/tb-drugresistance-guideline\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/publications\/tb-drugresistance-guideline\/en\/<\/ext-link>."},{"key":"ref12","unstructured":"World Health Organization. Treatment of tuberculosis. Guidelines for national programmes, fourth edition 2010 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/publications\/9789241547833\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/publications\/9789241547833\/en\/<\/ext-link>."},{"key":"ref13","unstructured":"World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis 2014 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/publications\/pmdt_companionhandbook\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/publications\/pmdt_companionhandbook\/en\/<\/ext-link>."},{"key":"ref14","unstructured":"World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis (2016 update) 2016 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/areas-of-work\/drug-resistant-tb\/treatment\/resources\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/areas-of-work\/drug-resistant-tb\/treatment\/resources\/en\/<\/ext-link>."},{"key":"ref15","unstructured":"Ministerio de Salud del Per\u00fa. Norma tecnica de salud para el control de la tuberculosis 2006 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ftp:\/\/ftp2.minsa.gob.pe\/descargas\/dgsp\/ESN-tuberculosis\/normaspublicaciones\/NTSTBC.pdf\" xlink:type=\"simple\">ftp:\/\/ftp2.minsa.gob.pe\/descargas\/dgsp\/ESN-tuberculosis\/normaspublicaciones\/NTSTBC.pdf<\/ext-link>."},{"key":"ref16","unstructured":"Ministerio de Salud del Per\u00fa. Actualizaci\u00f3n del sub numeral 7. tratamiento de la tuberculosis de la nts n\u00ba 041-minsa\/dgsp-v.01 \u201cNorma t\u00e9cnica de salud para el control de la tuberculosis\u201d 2010 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/ftp:\/\/ftp2.minsa.gob.pe\/descargas\/dgsp\/ESN-tuberculosis\/normaspublicaciones\/VFCapTrat.pdf\" xlink:type=\"simple\">ftp:\/\/ftp2.minsa.gob.pe\/descargas\/dgsp\/ESN-tuberculosis\/normaspublicaciones\/VFCapTrat.pdf<\/ext-link>."},{"key":"ref17","unstructured":"Ministerio de Salud del Per\u00fa. Norma Tecnica de Salud para la Atencion Integral de las personas afectadas por tuberculosis 2013 [cited 2016 20\/09\/16]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.minsa.gob.pe\/dgsp\/observatorio\/documentos\/infecciones\/RM715-2013_MINSA_TB.pdf\" xlink:type=\"simple\">http:\/\/www.minsa.gob.pe\/dgsp\/observatorio\/documentos\/infecciones\/RM715-2013_MINSA_TB.pdf<\/ext-link>."},{"issue":"2","key":"ref18","first-page":"197","article-title":"Propuesta de esquemas de tratamiento antituberculosis basados en la susceptibilidad a isoniacida y rifampicina","volume":"30","author":"A Mendoza","year":"2013","journal-title":"Rev Peru Med Exp Salud Publica"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1473-3099(16)30407-8","article-title":"Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis","volume":"17","author":"M Gegia","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"ref20","unstructured":"World Health Organization. Definitions and reporting framework for tuberculosis 2013 revision, updated December 2014 2013 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/tb\/publications\/definitions\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/tb\/publications\/definitions\/en\/<\/ext-link>."},{"key":"ref21","unstructured":"Ministerio de Salud del Per\u00fa. Impacto socioecon\u00f3mico de la tuberculosis en el Per\u00fa 2010 2013 [Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.tuberculosis.minsa.gob.pe\/\" xlink:type=\"simple\">http:\/\/www.tuberculosis.minsa.gob.pe\/<\/ext-link>."},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0152933","article-title":"Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin Mono-Resistant Pulmonary Tuberculosis in Lima, Peru","volume":"11","author":"L Villegas","year":"2016","journal-title":"Plos One"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1000150","article-title":"Standardized Treatment of Active Tuberculosis in patients with previous treatment and\/or with mono-resistance to Isoniazid: A systematic review and meta-analysis","volume":"6","author":"D Menzies","year":"2009","journal-title":"PLoS Med"},{"issue":"6","key":"ref24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jinf.2010.03.017","article-title":"Isoniazid-resistant tuberculosis in Denmark: Mutations, transmission and treatment outcome","volume":"60","author":"D Bang","year":"2010","journal-title":"J Infect"},{"issue":"17","key":"ref25","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1407426","article-title":"Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis","volume":"371","author":"S Gillespie","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"ref26","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJMoa1315817","article-title":"A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis","volume":"371","author":"C Merle","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"ref27","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1314210","article-title":"High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis","volume":"371","author":"A Jindani","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1128\/AAC.01377-15","article-title":"Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary Tuberculosis","volume":"60","author":"H Lee","year":"2016","journal-title":"Antimicrobial Agents and Chemotherapy"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206658","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:53:51Z","timestamp":1588971231000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206658"}},"subtitle":[],"editor":[{"given":"Mark Patrick","family":"Nicol","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,4]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206658","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,4]]}}}